Earlier, UBS initiated coverage on LipoScience (NASDAQ: LPDX) with a Buy. PT $16.00.

The firm comments, "We are positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE